Skip to main contentSkip to navigationSkip to search
Resolutions at Sleep Cycle’s Annual General Meeting 2022
May 10, 2022, 11:15
Regulatory information
At the Annual General Meeting (the “AGM”) of Sleep Cycle AB (publ) on 10 May 2022, the following was resolved.


Adoption of the income statement and the balance sheet

The AGM adopted the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet for the financial year 2021.

Allocation of profit

The AGM decided that no distribution of dividend should be made for the financial year 2021 and that the retained profits shall be carried forward to the new accounts.

Discharge from liability
The Board members and the CEO were discharged from liability for their administration of the company for the financial year 2021.

Election of Board of Directors
Lars Berg, Ödgärd Andersson, Anne Broeng, Rasmus Järborg and Olof Nilsson were re-elected as members of the Board. Lars Berg was re-elected as Chairperson of the Board.

Board remuneration
The AGM resolved that Board fees shall continue to be paid with SEK 500,000 to the Chairperson and SEK 250,000 to each of the other Board members elected by the AGM. For work in the Audit Committee, the AGM resolved that a fee of SEK 100,000 shall be paid to the Chairperson and a fee of SEK 50,000 shall be paid to each other member of the Audit Committee. For work in the Remuneration Committee, a fee of SEK 50,000 shall continue to be paid to the Chairperson and a fee of SEK 25,000 shall continue to be paid to each other member of the Remuneration Committee.

Election of auditor and auditor fees
Mazars AB was re-elected as auditor of the company until the next AGM. It was resolved that fees to the auditor shall be paid in accordance with approved invoice.

Remuneration report
The AGM resolved to approve the Board of Directors’ remuneration report pursuant to Chapter 8, Section 53 a of the Swedish Companies Act, regarding the financial year 2021.

Resolution on incentive program
In accordance with the proposal of the Board of Directors, the AGM resolved to adopt an incentive program for employees in the group by a directed issue of warrants with the right to subscribe for new shares in the company. The company shall issue a maximum of 100,000 warrants that give the right to subscribe for 100,000 new shares. The right to subscribe for the warrants shall, with deviation from the shareholders’ preferential right, accrue to the participants of the program. Subscription of shares by exercise of subscription warrants shall take place during the period from and including 1 August 2025 up to and including 31 August 2025. The subscription price per share shall correspond to 135 percent of the volume-weighted average value according to Nasdaq Stockholm’s official price list for shares in the company during the period of ten trading days preceding the general meeting. In the event that all warrants are exercised, the number of shares will increase by 100,000, which corresponds to a dilution of a maximum of approximately 0.5 percent of the shares and votes based on the company’s current number of shares.

To learn more about Sleep Cycle and its capabilities, visit

Media contacts:

Per Andersson
CFO och Head of Investor Relations

[email protected]
+46 70 939 5327

Malin Abrahamsson
Head of PR
[email protected]
+46 73 972 6424

About Sleep Cycle
With millions of active users and over 400 million nights analyzed in more than 150 countries, Sleep Cycle is the leading sleep tracker application and one of the most widely used solutions worldwide to improve sleep health. Sleep Cycle’s mission is to improve global health by empowering people to sleep better. Since its launch in 2009, Sleep Cycle has helped millions of people understand their sleeping habits and improve their sleep. Sleep Cycle is one of the world’s most comprehensive sources for statistics, frequently contributing to sleep research by collaborating with renowned universities and research facilities worldwide. Sleep Cycle is regularly featured in notable media outlets covering the product and the company’s released Sleep reports. Sleep Cycle ( is listed on Nasdaq Stockholm under the ticker SLEEP.